SE9201331D0 - Protein l och hybridproteiner daerav - Google Patents

Protein l och hybridproteiner daerav

Info

Publication number
SE9201331D0
SE9201331D0 SE9201331A SE9201331A SE9201331D0 SE 9201331 D0 SE9201331 D0 SE 9201331D0 SE 9201331 A SE9201331 A SE 9201331A SE 9201331 A SE9201331 A SE 9201331A SE 9201331 D0 SE9201331 D0 SE 9201331D0
Authority
SE
Sweden
Prior art keywords
proteins
protein
sequences
relates
hybrid proteins
Prior art date
Application number
SE9201331A
Other languages
English (en)
Swedish (sv)
Inventor
U Sjoebring
Original Assignee
Hightech Receptor C O Active
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hightech Receptor C O Active filed Critical Hightech Receptor C O Active
Priority to SE9201331A priority Critical patent/SE9201331D0/xx
Publication of SE9201331D0 publication Critical patent/SE9201331D0/xx
Priority to JP51918393A priority patent/JP3462209B2/ja
Priority to US08/325,278 priority patent/US6822075B2/en
Priority to PCT/SE1993/000375 priority patent/WO1993022342A1/fr
Priority to DE69333042T priority patent/DE69333042T2/de
Priority to EP93912053A priority patent/EP0662086B1/fr
Priority to US08/795,475 priority patent/US5965390A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9201331A 1992-04-28 1992-04-28 Protein l och hybridproteiner daerav SE9201331D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9201331A SE9201331D0 (sv) 1992-04-28 1992-04-28 Protein l och hybridproteiner daerav
JP51918393A JP3462209B2 (ja) 1992-04-28 1993-04-28 プロテインｌおよびそのハイブリッドプロテイン類
US08/325,278 US6822075B2 (en) 1992-04-28 1993-04-28 Protein L and hybrid proteins thereof
PCT/SE1993/000375 WO1993022342A1 (fr) 1992-04-28 1993-04-28 Proteine l et ses proteines hybrides
DE69333042T DE69333042T2 (de) 1992-04-28 1993-04-28 Protein l und entsprechenden proteinhybriden
EP93912053A EP0662086B1 (fr) 1992-04-28 1993-04-28 Proteine l et ses proteines hybrides
US08/795,475 US5965390A (en) 1992-04-28 1997-02-11 Protein L and hybrid proteins thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201331A SE9201331D0 (sv) 1992-04-28 1992-04-28 Protein l och hybridproteiner daerav

Publications (1)

Publication Number Publication Date
SE9201331D0 true SE9201331D0 (sv) 1992-04-28

Family

ID=20386082

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201331A SE9201331D0 (sv) 1992-04-28 1992-04-28 Protein l och hybridproteiner daerav

Country Status (6)

Country Link
US (2) US6822075B2 (fr)
EP (1) EP0662086B1 (fr)
JP (1) JP3462209B2 (fr)
DE (1) DE69333042T2 (fr)
SE (1) SE9201331D0 (fr)
WO (1) WO1993022342A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
US7037680B2 (en) * 1993-09-21 2006-05-02 The United States Of America As Represented By The Secretary Of The Army Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy
AUPM885194A0 (en) * 1994-10-14 1994-11-10 Council Of The Queensland Institute Of Medical Research, The Synthetic peptides and vaccines comprising same
CA2249455A1 (fr) * 1996-03-26 1997-10-02 Amrad Operations Pty. Ltd. Precurseurs d'anticorps catalytiques
AUPO930697A0 (en) * 1997-09-19 1997-10-09 Walter And Eliza Hall Institute Of Medical Research, The Catalytic antibodies and a method of producing same
US20040154053A1 (en) * 1998-03-20 2004-08-05 Wyatt Paul Signal transduction protein involved in plant dehiscence
EP1114161B1 (fr) 1998-09-14 2004-03-03 Affitech As Proteine de liaison de l'immunoglobuline
US7345217B2 (en) 1998-09-22 2008-03-18 Mendel Biotechnology, Inc. Polynucleotides and polypeptides in plants
US8124348B2 (en) 2000-08-23 2012-02-28 Jonathan Zmuda Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes
US7939715B2 (en) 2000-11-16 2011-05-10 Mendel Biotechnology, Inc. Plants with improved yield and stress tolerance
NZ526822A (en) * 2000-12-19 2005-03-24 Sembiosys Genetics Inc Methods for the production of multimeric proteins for producing an oil body associated with a recombinant protein complex preferably thioredoxin or an immunoglobin, in transgenic plants and their use in compositons for reducing allergenicity of food
US7098383B2 (en) * 2000-12-19 2006-08-29 Sembiosys Genetics Inc. Methods for the production of multimeric immunoglobulins, and related compositions
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
US8426678B2 (en) 2002-09-18 2013-04-23 Mendel Biotechnology, Inc. Polynucleotides and polypeptides in plants
US7255867B2 (en) * 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
WO2004076634A2 (fr) * 2003-02-24 2004-09-10 Ira Sanders Translocation par membrane cellulaire d'inhibiteurs snare régulés, compositions associées et procédés de traitement de pathologies
JP2005112827A (ja) * 2003-10-10 2005-04-28 National Institute Of Advanced Industrial & Technology 抗体アフィニティ担体
WO2005113584A1 (fr) * 2004-04-29 2005-12-01 Board Of Regents, University Of Texas System Methodes et compositions contenant des domaines liant les ig de la proteine l pour le ciblage specifique de cellule
US8221998B2 (en) * 2005-05-20 2012-07-17 Glaxosmithkline Llc Expression of protein GB1 domain fusion proteins in mammalian cells
US7741128B2 (en) * 2005-05-23 2010-06-22 University Of Hawaii Cooperative reporter systems, components, and methods for analyte detection
US10822396B2 (en) * 2009-12-15 2020-11-03 MuHyeon CHOE Repeat-chain for the production of dimer, multimer, multimer complex and super-complex
AU2012328322A1 (en) 2011-10-27 2014-06-12 Genmab A/S Production of heterodimeric proteins
WO2014193193A1 (fr) * 2013-05-30 2014-12-04 Choe Muhyeon Super-complexe formé par liaison croisée entre des complexes de chaîne répétitive et de monomère, et son utilisation
US9569513B1 (en) * 2013-09-10 2017-02-14 Amazon Technologies, Inc. Conditional master election in distributed databases
JP6731345B2 (ja) 2014-08-28 2020-07-29 株式会社カネカ 免疫グロブリンｇ結合性ペプチド
JP6369807B2 (ja) * 2014-10-21 2018-08-08 株式会社プロテイン・エクスプレス プロテインｌ変異体
DK3233892T3 (da) 2014-12-17 2024-04-08 Cytiva Bioprocess R & D Ab Modificerede kappa-letkæde-bindende polypeptider
EP3252158A4 (fr) 2015-01-26 2018-07-18 Kaneka Corporation Peptide de liaison de région variable de chaîne kappa d'immunoglobuline mutant
JPWO2016121701A1 (ja) * 2015-01-26 2017-11-09 株式会社カネカ 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
WO2017191747A1 (fr) * 2016-05-06 2017-11-09 株式会社カネカ Procédé de production d'une protéine comprenant une région variable de chaîne κ
WO2017195638A1 (fr) 2016-05-09 2017-11-16 株式会社カネカ Procédé de purification d'un anticorps ou d'un fragment d'anticorps comportant une région variable de chaîne κ
JP6983419B2 (ja) * 2017-02-08 2021-12-17 国立大学法人東京工業大学 抗原検出又は測定用キット
WO2021252498A1 (fr) 2020-06-12 2021-12-16 New England Biolabs, Inc. Compositions et procédés de détection de cibles moléculaires sur l'adn chromosomique
WO2022216157A1 (fr) * 2021-04-09 2022-10-13 Stichting Radboud Universiteit Enzyme de biotinylation de proximité immédiate
GB202112386D0 (en) 2021-08-31 2021-10-13 Cytiva Bioprocess R & D Ab Modified kappa light chain-binding polypeptides
GB202203640D0 (en) 2022-03-16 2022-04-27 Cytiva Bioprocess R & D Ab Alkali-stabilized kappa light chain-binding separation matrix
WO2023247468A2 (fr) 2022-06-22 2023-12-28 Puridify Limited Matrice de convection de liaison à une chaîne légère kappa

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE459503B (sv) * 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
US5312901A (en) 1986-02-14 1994-05-17 Pharmacia Lkb Biotechnology Ab Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
SE459662B (sv) 1986-03-21 1989-07-24 Pharmacia Ab Hybrid-dna-molekyl som kodar foer ett protein med samma igg specificitet som protein g, plasmid innehaallande densamma samt foerfarande foer framstaellning av proteinet
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
JP2871709B2 (ja) * 1988-11-21 1999-03-17 住友製薬株式会社 免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法
SE466259B (sv) * 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
SE9002212D0 (sv) * 1990-06-21 1990-06-21 Hightech Receptor Ab Igg binding protein
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
WO1993022439A1 (fr) * 1992-05-07 1993-11-11 Microbiological Research Authority Proteines fixatrices de l'immunoglobuline derivees de la proteine l et leurs utilisations
US5977336A (en) * 1993-03-16 1999-11-02 St. Louis University High molecular weight surface proteins of non-typeable haemophilus
EP1114161B1 (fr) * 1998-09-14 2004-03-03 Affitech As Proteine de liaison de l'immunoglobuline
GB9929937D0 (en) * 1999-12-17 2000-02-09 Actinova Ltd Antigen delivery

Also Published As

Publication number Publication date
JPH07506573A (ja) 1995-07-20
US6822075B2 (en) 2004-11-23
EP0662086B1 (fr) 2003-06-11
US20030027283A1 (en) 2003-02-06
JP3462209B2 (ja) 2003-11-05
DE69333042T2 (de) 2004-05-06
EP0662086A1 (fr) 1995-07-12
WO1993022342A1 (fr) 1993-11-11
DE69333042D1 (de) 2003-07-17
US5965390A (en) 1999-10-12

Similar Documents

Publication Publication Date Title
SE9201331D0 (sv) Protein l och hybridproteiner daerav
CA2290485A1 (fr) Procede de production de proteines non immunogenes
ATE130765T1 (de) Gentechnologisch veränderte immunglobuline.
ATE213507T1 (de) Methode zur bindung von material an das beta- amyloid-peptid
ATE353362T1 (de) Neuartige ctla4/cd28 liganden und deren anwendungen
DK19290D0 (da) Molekulaer samling af antistofgener, antistoffer fremstillet derved samt anvendelse deraf
DE69131580D1 (de) GDF-1 und UOG1 Proteine
DE69637148D1 (de) Nukleinsäuremoleküle, proteine und peptide, die im zusammenhang stehen mit dickdarmzellen und dickdarm-krebszellen
EP1862472A3 (fr) Protéine de Chlamydia, séquence génétique et utilisations associées
DE69932813D1 (de) Nukleinsäurebindungsproteine
CY1113218T1 (el) Υβριδιο και διμερης εκφραση πρωτεϊνων ναϊσσεριας
WO2003092630A3 (fr) Identification d'anticorps monoclonaux humains largement neutralisants a reaction croisee au moyen d'un procede d'adherence sequentielle sur plaque d'antigenes de banques de presentation du phage
DK0640135T3 (da) Immunoglobulinbindende proteiner, der er afledt af protein L, og anvendelser af disse
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
WO1997008314A3 (fr) Facteur de liaison telomerique, son utilisation diagnostique et therapeutique
ATE177758T1 (de) Synthetische peptide, antikörper dagegen und ihre verwendung
DE69433690D1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
GB9307371D0 (en) Fusion proteins
ATE258598T1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
DE69333382D1 (de) Hyaluronan rezeptor (rezeptor durch hyaluronan verurzachte bewelichkeit) und hyaluronan bindende peptide
WO1998021333A3 (fr) Acide nucleique codant des proteines de fixation de la schwannomine et produits associes
EP1576157A4 (fr) Proteines fluorescentes fabriquees a partir de copepodes et procedes d'utilisation correspondants
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
AU4375493A (en) Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof
NZ500151A (en) A general method for attaching DNA molecule comprising non-antibody target molecule (eg. CTLA-4 or L-selectin), antigen or epitope sequence, and optionally a polypeptide sequence